Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival - PubMed (original) (raw)
Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival
Paul R van Ginkel et al. Cancer Res. 2004.
Abstract
Metastatic tumor cells originating from cancers of a variety of tissues such as breast, skin, and prostate may remain dormant for long periods of time. In the case of uveal melanoma, the principal malignancy of the eye, complete removal of the primary tumor by enucleation can nonetheless be followed by metastatic tumor growth in distant organs months, years, or even decades later. This suggests that tumor cells have already spread to secondary sites at the time of treatment and remain dormant as micrometastases. Identifying factors that govern long-lived survival of metastatic tumor cells is therefore key to decreasing mortality associated with this and other diseases. While investigating factors differentially expressed in melanoma cells and normal melanocytes, we identified the receptor tyrosine kinase Axl and found up-regulation of Axl in uveal melanomas and melanoma cell lines by RNase protection, Western analysis, and immunohistochemistry. Axl has been shown to mediate cell growth and survival through its ligand Gas6 in non-transformed cells. To test whether stimulation of Axl can enhance survival of uveal melanoma cells, we assessed the degree of mitogenesis and cell survival by bromodeoxyuridine incorporation and trypan blue exclusion, respectively, upon stimulation of Mel 290 uveal melanoma cells with Gas6 in vitro. We show that Gas6 mediates mitogenesis and cell survival in Mel 290 cells. We further demonstrate that these effects occur specifically through the Axl receptor by modulating the expression of Axl with an antisense construct. cDNA microarray analysis of 12,687 genes then revealed that Gas6 stimulation of Axl in Mel 290 cells results primarily in the down-regulation of Cyr61, a member of the CCN protein family involved in tumor progression. These data show that the Axl pathway mediates increased survival of uveal melanoma cells, potentially advantageous during cancer dormancy, and that Axl may function in part through regulation of Cyr61.
Similar articles
- Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway.
Sawabu T, Seno H, Kawashima T, Fukuda A, Uenoyama Y, Kawada M, Kanda N, Sekikawa A, Fukui H, Yanagita M, Yoshibayashi H, Satoh S, Sakai Y, Nakano T, Chiba T. Sawabu T, et al. Mol Carcinog. 2007 Feb;46(2):155-64. doi: 10.1002/mc.20211. Mol Carcinog. 2007. PMID: 17186543 - Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor.
Sainaghi PP, Castello L, Bergamasco L, Galletti M, Bellosta P, Avanzi GC. Sainaghi PP, et al. J Cell Physiol. 2005 Jul;204(1):36-44. doi: 10.1002/jcp.20265. J Cell Physiol. 2005. PMID: 15605394 - Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.
Gustafsson A, Martuszewska D, Johansson M, Ekman C, Hafizi S, Ljungberg B, Dahlbäck B. Gustafsson A, et al. Clin Cancer Res. 2009 Jul 15;15(14):4742-9. doi: 10.1158/1078-0432.CCR-08-2514. Epub 2009 Jun 30. Clin Cancer Res. 2009. PMID: 19567592 - A review on the role of GAS6 and GAS6-AS1 in the carcinogenesis.
Ghafouri-Fard S, Khoshbakht T, Taheri M, Mokhtari M. Ghafouri-Fard S, et al. Pathol Res Pract. 2021 Oct;226:153596. doi: 10.1016/j.prp.2021.153596. Epub 2021 Aug 25. Pathol Res Pract. 2021. PMID: 34481213 Review. - Recent progress on the role of Axl, a receptor tyrosine kinase, in malignant transformation of myeloid leukemias.
Neubauer A, Burchert A, Maiwald C, Gruss HJ, Serke S, Huhn D, Wittig B, Liu E. Neubauer A, et al. Leuk Lymphoma. 1997 Mar;25(1-2):91-6. doi: 10.3109/10428199709042499. Leuk Lymphoma. 1997. PMID: 9130617 Review.
Cited by
- Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
Jiang T, Liu G, Wang L, Liu H. Jiang T, et al. PLoS One. 2015 Jul 24;10(7):e0133940. doi: 10.1371/journal.pone.0133940. eCollection 2015. PLoS One. 2015. PMID: 26207647 Free PMC article. - Heterogeneity and molecular landscape of melanoma: implications for targeted therapy.
Beigi YZ, Lanjanian H, Fayazi R, Salimi M, Hoseyni BHM, Noroozizadeh MH, Masoudi-Nejad A. Beigi YZ, et al. Mol Biomed. 2024 May 10;5(1):17. doi: 10.1186/s43556-024-00182-2. Mol Biomed. 2024. PMID: 38724687 Free PMC article. Review. - Comparison of growth factor signalling pathway utilisation in cultured normal melanocytes and melanoma cell lines.
Kim JE, Stones C, Joseph WR, Leung E, Finlay GJ, Shelling AN, Phillips WA, Shepherd PR, Baguley BC. Kim JE, et al. BMC Cancer. 2012 Apr 4;12:141. doi: 10.1186/1471-2407-12-141. BMC Cancer. 2012. PMID: 22475322 Free PMC article. - Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.
Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, Evans DB, Wang H. Song X, et al. Cancer. 2011 Feb 15;117(4):734-43. doi: 10.1002/cncr.25483. Epub 2010 Oct 4. Cancer. 2011. PMID: 20922806 Free PMC article. - The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.
Koorstra JB, Karikari CA, Feldmann G, Bisht S, Rojas PL, Offerhaus GJ, Alvarez H, Maitra A. Koorstra JB, et al. Cancer Biol Ther. 2009 Apr;8(7):618-26. doi: 10.4161/cbt.8.7.7923. Epub 2009 Apr 22. Cancer Biol Ther. 2009. PMID: 19252414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous